Post-traumatic stress disorder, treatment of obsessive-compulsive disorder and related neuropsychiatric disorders

摘要

(57) [summary] The present invention describes a new treatment of neuropsychiatric disorders. This failure, nerve schizophrenic symptoms anxiety disorders, mood disorders, psychotic disorders, somatoform disorders, and results from the movement disorders. Treatment of the present invention utilize any agent that acts at the same time as the GABA-A receptor agonist and NMDA glutamate receptor antagonist. These two activities are characteristic of the single agents, for example, pro Akamu insert preferably is (N- acetylhomopiperazine Tauri calcium sulfonates). Alternatively, to obtain combined as a compound or mixture, the separate agents with these activities, and may be administered together thereby. Further, the present invention, there is provided a third agent that acts as an ion channel blocker or noncompetitive NMDA receptor blocking agent. This enhances the effect of the major treatment. Preferred ion channel blockers particular is magnesium.